Live
Breast cancer
Breast cancer is a cancer that develops from breast tissue. Signs of breast cancer may include: a lump in the breast, a change in breast shape, dimpling of the skin, milk rejection, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.
2,451trials recruiting now
United Statesmost trial sites (761)
400+mapped site locations
Fudan Universitymost active sponsor
Breakdowns below use the 2,000 most relevant recruiting trials.
Trials by phase
Phase 1 tests safety, phase 2 tests whether it works, phase 3 compares it with standard care, phase 4 follows it after approval.
Countries with the most trials
Where trials are recruiting
Each dot is a site city; bigger dots have more recruiting trials. Showing up to 400 locations.
Lead sponsors
Fudan University · 66Memorial Sloan Kettering Cancer Center · 43Mayo Clinic · 28Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 28M.D. Anderson Cancer Center · 26Second Affiliated Hospital, Zhejiang University, School of Medicine · 23National Cancer Institute (NCI) · 21UNC Lineberger Comprehensive Cancer Center · 20
Newest recruiting trials
- Early phase 1
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
- Phase 3
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
- Phase 1
HER2 Vaccine for Locally Advanced Breast Cancer
- Phase 3
A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment
- Not applicable (device/behavioral)
A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors
- Not applicable (device/behavioral)
Gryrotonic Training in Behcet-diseased Elders With Breast Cancer
- Phase 1
A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer
- Observational study
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
- Not applicable (device/behavioral)
Effects of a Mindful Self-Compassion Intervention on Psychological Adjustment in Breast Cancer Survivors
- Not applicable (device/behavioral)
Pectoral Nerve Block Versus Serratus Posterior Superior Intercostal Plane Block for Pain Control After Mastectomy
- Observational study
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
- Phase 4
FES PET/MRI for Occult Disease in Lobular Breast Cancer
- Phase 1
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Observational study
Improved Facial Skin Quality and Quality of Life After VYC-12L Treatment in Breast Cancer Survivors
- Phase 2
A Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)
- Phase 1
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Not applicable (device/behavioral)
A Study of Skipping Radiation Therapy in People With Breast Cancer
- Not applicable (device/behavioral)
Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2
- Not applicable (device/behavioral)
BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies
- Not applicable (device/behavioral)
Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors
- Not applicable (device/behavioral)
Researching the Effect of Exercise on Cancer
- Observational study
Pre-Treatment Breast DCE-MRI AI Model to Predict Neoadjuvant Chemotherapy Benefit in Locally Advanced Triple-Negative Breast Cancer
- Observational study
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
- Phase 1
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
- Not applicable (device/behavioral)
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
See all 2,451 on ClinicalTrials.gov →
General information only, not medical advice. Trial listings are written by sponsors; eligibility and contacts are on each official listing.